Clinical Trial Update: N-acetyl Cysteine: the Effectiveness and Safety in a Cohort of Pediatric Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effectiveness and safety of N-acetylcysteine in pediatric patients with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease in Children

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Beni-Suef University | Conditions: Chronic Kidney Diseases | Phase 2 | Status: COMPLETED